Tretazicar

Base Information

• Chemical Name: Tretazicar
• CAS No.: 21919-05-1
• Molecular Formula: C9H8N4O5
• Molecular Weight: 252.186
• Hs Code.: 2933990090
• European Community (EC) Number: 606-863-5
• NSC Number: 115829
• UNII: 7865D5D01M
• DSSTox Substance ID: DTXSID00176335
• Nikkaji Number: J22.077I
• Wikidata: Q27095075
• NCI Thesaurus Code: C81554
• Metabolomics Workbench ID: 148718
• ChEMBL ID: CHEMBL23330
• Mol file: 21919-05-1.mol

Synonyms:5-(1-aziridinyl)-2,4-dinitrobenzamide;5-aziridinyl-2,4-dinitrobenzamide;aziridine dinitrobenzamide;CB 1954;CB-1954;CB1954;tretazicar

Chemical Property of Tretazicar

Chemical Property:

• Vapor Pressure: 1.66E-07mmHg at 25°C
• Melting Point: 173 °C
• Refractive Index: 1.714
• Boiling Point: 427.2 °C at 760 mmHg
• PKA: 14.23±0.50(Predicted)
• Flash Point: 212.2 °C
• PSA: 137.74000
• Density: 1.671 g/cm³
• LogP: 2.23360
• Storage Temp.: 2-8°C
• Solubility.: Acetonitrile (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Sl
• XLogP3: 0
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 6
• Rotatable Bond Count: 2
• Exact Mass: 252.04946937
• Heavy Atom Count: 18
• Complexity: 385

Purity/Quality:

98%,99%, ^*data from raw suppliers

Tretazicar(>94%) ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-]
• Recent EU Clinical Trials: A PHASE 2 STUDY OF THE ANTI-TUMOUR ACTIVITY AND SAFETY OF PROLARIX? IN HEPATOCELLULAR CARCINOMA (HCC)
• Description: CB-1954 is a prodrug that is enzymatically activated to generate an antitumor agent that forms DNA-DNA interstrand crosslinks. In rat Walker 256 carcinoma cells, CB-1954 is reduced by NAD(P)H:quinone oxidoreductase (NQO1) to the cytotoxic derivative 5-(aziridin-1-yl)-4-hydroxylamineo 2 nitrobenzamide, a bifunctional alkylating agent.
• Uses: 5-Aziridino-2,4-dinitrobenzamide is an anticancer prodrug used in gene therapy research and is known to be activated by NAD(P)H Quinone Oxidoreductase 2. Tretazicar is an anticancer prodrug used in gene therapy research and is known to be activated by NAD(P)H Quinone Oxidoreductase 2.